Brexpiprazole

Brexpiprazole (CAS 913611-97-9) from Polpharma is offered as a high chemical purity anhydrous polymorph (Form I) with no N-nitrosamine impurities and high polymorphic purity after micronization, supported by EU, Brazilian, and US drug master file (DMF) readiness. Used as an antipsychotic to treat schizophrenia and, in combination with other medications, major depressive disorder, it is manufactured directly by Polpharma to pharmaceutical grade under in-house standards, with samples available, and sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.